PURPOSE: To compare diffusivity values between malignant and benign focal hepatic lesions using the intravoxel incoherent motion model. MATERIALS AND METHODS: This study included 84 focal hepatic lesions in 84 patients. Final diagnoses were as follows: hepatocellular carcinoma (n = 45), cholangiocarcinoma (n = 6), metastatic liver tumor (n = 3), cyst (n = 20), hemangioma (n = 5), inflammatory pseudotumor (n = 2), abscess (n = 2), and focal nodular hyperplasia (n = 1). Diffusion-weighted images at 12 b-values were used to obtain the diffusion coefficient of pure molecular diffusion (D), diffusion coefficient of microcirculation or perfusion-related diffusion (D*), and perfusion-related diffusion fraction (f). Parameters of malignant and benign focal hepatic lesions were compared using the Wilcoxon test. The diagnostic performance for distinguishing between malignant and benign hepatic lesions was also analyzed. RESULTS: Both the D value (1.15 ± 0.21 × 10(-3) mm(2) /s [mean ± standard deviation]) and D* value (62.7 ± 12.7 × 10(-3) mm(2) /s) in malignant lesions was significantly lower than that in benign lesions (D value [2.46 ± 0.45× 10(-3) mm(2) /s], P < 0.0001; D* value [87.6 ± 35.3 × 10(-3) mm(2) /s], P = 0.0008). The f value did not differ significantly between malignant (25.0 15.1 ± 15.1%) and benign lesions (30.1 ± 16.3%). CONCLUSION: D* and D values were suppressed in malignant lesions. However, the D value was more reliable for distinguishing between malignant and benign focal hepatic lesions.
PURPOSE: To compare diffusivity values between malignant and benign focal hepatic lesions using the intravoxel incoherent motion model. MATERIALS AND METHODS: This study included 84 focal hepatic lesions in 84 patients. Final diagnoses were as follows: hepatocellular carcinoma (n = 45), cholangiocarcinoma (n = 6), metastatic liver tumor (n = 3), cyst (n = 20), hemangioma (n = 5), inflammatory pseudotumor (n = 2), abscess (n = 2), and focal nodular hyperplasia (n = 1). Diffusion-weighted images at 12 b-values were used to obtain the diffusion coefficient of pure molecular diffusion (D), diffusion coefficient of microcirculation or perfusion-related diffusion (D*), and perfusion-related diffusion fraction (f). Parameters of malignant and benign focal hepatic lesions were compared using the Wilcoxon test. The diagnostic performance for distinguishing between malignant and benign hepatic lesions was also analyzed. RESULTS: Both the D value (1.15 ± 0.21 × 10(-3) mm(2) /s [mean ± standard deviation]) and D* value (62.7 ± 12.7 × 10(-3) mm(2) /s) in malignant lesions was significantly lower than that in benign lesions (D value [2.46 ± 0.45× 10(-3) mm(2) /s], P < 0.0001; D* value [87.6 ± 35.3 × 10(-3) mm(2) /s], P = 0.0008). The f value did not differ significantly between malignant (25.0 15.1 ± 15.1%) and benign lesions (30.1 ± 16.3%). CONCLUSION: D* and D values were suppressed in malignant lesions. However, the D value was more reliable for distinguishing between malignant and benign focal hepatic lesions.
Authors: Lukas Filli; Moritz C Wurnig; Roger Luechinger; Christian Eberhardt; Roman Guggenberger; Andreas Boss Journal: Eur Radiol Date: 2015-01-10 Impact factor: 5.315
Authors: Tiffany P Hennedige; James Thomas Patrick Decourcy Hallinan; Fiona P Leung; Lynette Li San Teo; Sridhar Iyer; Gang Wang; Stephen Chang; Krishna Kumar Madhavan; Aileen Wee; Sudhakar K Venkatesh Journal: Eur Radiol Date: 2015-06-02 Impact factor: 5.315
Authors: P Mürtz; A M Sprinkart; M Reick; C C Pieper; A-H Schievelkamp; R König; H H Schild; W A Willinek; G M Kukuk Journal: Eur Radiol Date: 2018-04-18 Impact factor: 5.315
Authors: Christian Eberhardt; Moritz C Wurnig; Andrea Wirsching; Cristina Rossi; Markus Rottmar; Pinar S Özbay; Lukas Filli; Mickael Lesurtel; Andreas Boss Journal: MAGMA Date: 2016-04-19 Impact factor: 2.310
Authors: Gene Young Cho; Linda Moy; Jeff L Zhang; Steven Baete; Riccardo Lattanzi; Melanie Moccaldi; James S Babb; Sungheon Kim; Daniel K Sodickson; Eric E Sigmund Journal: Magn Reson Med Date: 2014-10-09 Impact factor: 4.668